Abstract
This study was designed to assess the reliability and validity of a Quality of Life (QOL) instrument on a sample of 179 allogeneic Bone Marrow Transplant (BMT) survivors. The QOL-BMT tool was developed specifically for this population and was based on the investigators' prior research and a conceptual model of Quality of Life. Patients who were at least 100 days post BMT completed the 30 item visual analogue questionnaire. The instrument measured physical symptoms (e.g., weight loss, frequent colds, skin changes, cataracts, sexual problems), psychological to illness, social concerns (e.g., relationship adjustment, return to work), and spiritual well-being (e.g., sense of control, future goals). Psychometric analysis of the instrument included measures of reliability and validity. The study findings demonstrate the unique aspects of QOL dimensions in BMT survivors and the value of QOL assessment in clinical practice and research.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
BortinM, RimmA. Increasing utilization of bone marrow transplantation, II: results of the 1985–1987 survey.Transplantation 1989;48: 453.
WolcottDL, WellischDK, FawzyIF. Adaptation of adult bone marrow transplant recipient long-term survivors.Transplantation 1986;41: 478–484.
HabermanMR. Psychosocial aspects of bone marrow transplantation.Semin Oncol Nurs 1988;4: 55–59.
WingardJR, CurbowB, BakerF, et al. Health, functional status and employment of adult survivors of bone marrow transplantation.Ann Internal Med 1991;114: 113–118.
AndrykowskiMA, AltmaierEM, BarnettRL et al. The quality of life in adult survivors of A 31, four with notched renal transplant recipients.Transplantation 1990;5: 399–406.
Schmidt GM, Niland JC, Forman SJ,et al. Extended follow up in 212 long-term allogeneic bone marrow transplant survivors: addressing issues of quality of life.Transplantation (in press).
GrantM, PadillaG, FerrellB, RhinerM, et al. Assessment of quality of life with a single instrument.Semin Oncol Nurs 1990;6(4): 266–270.
SchipperH, LevittM. Measuring quality of life: risks and benefits.Cancer Treat Rep 1985;69: 1115–1123.
FettingJH. Evaluating quality and quantity of life in breast cancer adjuvant trials.J Clin Oncol 1988;6: 1795–1797.
WareJ. Conceptualizing disease impact and treatment outcomes.Cancer 1984;53: 316–323.
MorrisJN, SuissaS, SherwoodS, et al. Last days: a study of the quality of life of terminally ill cancer patients.J Chron Dis 1986;39: 47–62.
ZubrodCG, SchneidermanM, FreiE, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and trimethylene theophosporide.J Chron Dis 1960;1: 903.
AaronsonNK. Quality of life: What is it? How should it be measured?Oncology 1988;2: 69–74.
deHaesJCIM, vanOostromMA, UelvaartK. The effect of radical and conserving surgery on the quality of life of early breast cancer patients.Eur J Oncol 1986;12: 337–342.
SpitzerWO, DobsonAJ, HallJ, et al. Measuring the quality of life of cancer patients.J Chron Dis 1981;34: 585–597.
DonovanK, Sanson-FisherR, RedmanS. Measuring quality of life in cancer patients.J Clin Oncol 1989;7: 959–968.
BrownHN, KellyMJ: Stages of bone marrow transplantation: a psychiatric perspective.Psychosomatic Med 1976;38: 439–446.
DeegJH, StorbR, ThomasDE. Bone marrow transplantation: a review of delayed complications.Br J Haematol 1984;57: 185–208.
AndrykowskiMA, HensleePJ, FarrallMG. Physical and psychosocial functioning of adult survivors of allogenic BMT.Bone Marrow Transplantation 1989;4: 75–81.
FolsomT, PopkinM. Current and future perspectives on psychiatric involvement in bone marrow transplantations.Psychiatric Med 1987;4: 319–328.
WolcottDL, FawzyFI, WellischDK. Psychiatric aspects of BMT: a review and current issues.Psychiatric Med 1987;4: 299–317.
MashbergD, OstroffJ, LeskoL. Psychosexual sequelae among adult leukemia survivors.Proceed ASCO 1989;8: 311.
WolcottDL, WellischDK, FawzyFI, LandsverkJ. Psychological adjustment of adult bone marrow transplant donors whose recipient survives.Transplantation 1986;41(4): 484–488.
FerrellB, GrantM, SchmidtG, et al. The meaning of quality of life for bone marrow transplant survivors: Part I the impact of BMT on QOL.Cancer Nurs 1992;15(3): 153–160.
FerrellB, GrantM, SchmidtG, et al. The meaning of quality of life for bone marrow transplant survivors: Part II improving QOL for BMT survivors.Cancer Nurs 1992;15(4): 247–253.
FerrellB, WisdomC, WenzlC. Quality of life as an outcome variable in the management of cancer pain.Cancer 1989;63: 2321–2327.
PadillaG, FerrellB, GrantM, et al. Defining the content domain of quality of life for cancer patients with pain.Cancer Nurs 1990;13: 108–115.
FerrellB, GrantM, PadillaG. Experience of pain and perceptions of quality of life: validation of a conceptual model.Hospice J 1991;7(3): 9–24.
SpilkerB. Introduction. In: SpilkerB, ed.Quality of Life Assessments in Clinical Trials. New York: Raven Press, 1990: 3–9.
PadillaG, PresantC, GrantM, et al. Quality of life index for patients with cancer.Res Nurs Health 1983;6: 117–126.
NunnallyJC.Psychometric Theory 2nd ed. New York: McGraw Hill, 1978.
GrantMM, PadillaGV, PresantC, et al. Cancer Patients and Quality of Life.Proceedings of the Fourth National Conference on Cancer Nursing. Atlanta: American Cancer Society, 1984: 2–11.
PadillaGV. Validity of health-related quality of life subscales.Progress in Cardiovascular Nursing 1992;7(2): 13–20.
Author information
Authors and Affiliations
Additional information
This study was supported by the City of Hope National Medical Center, NCI Cancer Center Core Grant, R30 CA 33572 and the City of Hope BRSG Grant Support.
Rights and permissions
About this article
Cite this article
Grant, M., Ferrell, B., Schmidt, G.M. et al. Measurement of quality of life in bone marrow transplantation survivors. Qual Life Res 1, 375–384 (1992). https://doi.org/10.1007/BF00704432
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00704432